Definition for covered insulin for the insulin safety net program and manufacturer registration fee provision

This bill defines "covered insulin" for Minnesota's insulin safety net program as any prescribed insulin product used to treat diabetes, excluding those intended only for intravenous infusion. It establishes requirements for insulin manufacturers to provide affordable access to eligible individuals in urgent need, while exempting small manufacturers with annual Minnesota insulin sales under $2 million and products costing $8 or less per milliliter. The program allows uninsured Minnesota residents to receive a 30-day supply of covered insulin at no cost if they have less than a week's supply and face significant health risks without it. Pharmacies can dispense the insulin upon receipt of a completed application and prescription, with manufacturers reimbursing pharmacies for acquisition costs. The bill also classifies data collected through the program under existing privacy protections and repeals an outdated provision related to the safety net program.